Why US biotech stocks are back in favor

Now watching

Next video starts in : 7 Play

Why US biotech stocks are back in favor

Why US biotech stocks are back in favor
Replay video
Up next

Cramer: This high school class should be mandatory

Unlock your personal NFL Now stream by signing in to NFL.com

Why US biotech stocks are back in favor

by CNBC Videos 2:07 mins

While biotechnology shares are not cheap, they are no where near "bubble-like" valuations, says Bill Stone, Chief Investment Strategist at PNC Asset Management Group.

View Comments (0)